NeoCore Technology Co

NeoCore Technology Co P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of NeoCore Technology Co (4131.TWO) as of Nov 11, 2026 is -22.17. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -20.48 — a change of 8.27% (lower).

P/FCF

-22.17

YoY

8.27%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of NeoCore Technology Co is 2024 -22.17 . P/FCF (Price-to-Free-Cash-Flow Ratio) of NeoCore Technology Co was 2023 -20.48 . It decreases by 8.27% lower compared to the previous year.

The NeoCore Technology Co P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2017
41.48 TWD
Jan 1, 2018
-55.34 TWD
Jan 1, 2019
-326.25 TWD
Jan 1, 2020
-55.15 TWD
Jan 1, 2021
-90.03 TWD
Jan 1, 2022
-450.80 TWD
Jan 1, 2023
-20.48 TWD
Jan 1, 2024
-22.17 TWD
The NeoCore Technology Co P/FCF history
YEARP/FCFYoY
-22.17+8.27%
-20.48-95.46%
-450.80+400.70%
-90.03+63.24%
-55.15-83.09%
-326.25+489.52%
-55.34-233.43%
41.48-163.66%
-65.15-323.02%
29.21-331.97%
-12.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeoCore Technology Co Stock analysis

What does NeoCore Technology Co do? NeoCore Technology Co Ltd generates revenue through the sale of biochips and related biotechnology products. The company develops and manufactures DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, biochips, testing reagents, biological preparations, nucleic acid sequencing detection systems, biotechnology control hardware and software, and biomedical materials. These products are primarily sold within Taiwan and exported to Asian and European markets. The company's domestic sales focus on the Taiwanese market while international exports target Asian and European customers. DR. Chip Biotechnology, Inc. operates as the parent company for NeoCore Technology Co Ltd, managing the research, development, manufacturing, and sales of biochips. The business model relies on direct sales of its comprehensive product portfolio to domestic and international clients in the biotechnology sector. The company's product range serves both laboratory and commercial applications within the biotechnology industry. NeoCore Technology Co Ltd's revenue streams include the sale of biochips, DNA/RNA sample preparation kits, polymerase chain reaction kits, and related components. The company's export focus on Asia and Europe drives international sales, while domestic sales in Taiwan form a significant portion of its business. The company's product offerings cater to the needs of biotechnology laboratories and commercial entities requiring advanced biotech solutions. NeoCore Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeoCore Technology Co stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of NeoCore Technology Co is -22.17 in 2024.

P/FCF (Price-to-Free-Cash-Flow Ratio) of NeoCore Technology Co changed from -20.48 to -22.17, representing a 8.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) NeoCore Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s NeoCore Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — NeoCore Technology Co

All Key Metrics — NeoCore Technology Co